Clinical trial
High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell…
NCT00060255 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00060255 |
|---|---|
| Title | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors |
| Official title | Autologous Blood and Marrow Transplantation for Hematologic Malignancy and Selected Solid Tumors |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | busulfan, carboplatin, carmustine, cyclophosphamide, etoposide, melphalan, thiotepa, autologous bone marrow transplantation, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation and 1 more |
| Enrollment | 451 |
| Start date | Dec 1, 1991 |
| Primary completion | Aug 1, 2006 |
| Completion | Feb 1, 2013 |
| First posted | May 7, 2003 |
| Last update posted | May 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: